Trial Profile
The association between urinary glucose excretion and the water or caffein intake in subjects with Ipragliflozin in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Aug 2015 Status changed from not yet recruiting to completed, as reported by University Hospital Medical Information Network - Japan
- 01 Aug 2015 Number of treatment arms reduced from 4 to 3, as reported by University Hospital Medical Information Network - Japan.
- 01 Aug 2015 Planned number of patients changed from 6 to 8, as reported by University Hospital Medical Information Network - Japan